Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports the company's current revenue (TTM) is $91.32 B. In 2022 the company made a revenue of $94.94 B an increase over the years 2021 revenue that were of $93.77 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $91.32 B | -3.81% |
2022 | $94.94 B | 1.25% |
2021 | $93.77 B | 13.55% |
2020 | $82.58 B | 0.64% |
2019 | $82.05 B | 0.59% |
2018 | $81.58 B | 6.71% |
2017 | $76.45 B | 6.34% |
2016 | $71.89 B | 2.59% |
2015 | $70.07 B | -5.73% |
2014 | $74.33 B | 4.23% |
2013 | $71.31 B | 6.08% |
2012 | $67.22 B | 3.37% |
2011 | $65.03 B | 5.59% |
2010 | $61.58 B | -0.5% |
2009 | $61.89 B | -2.9% |
2008 | $63.74 B | 4.34% |
2007 | $61.09 B | 14.57% |
2006 | $53.32 B | 5.56% |
2005 | $50.51 B | 6.69% |
2004 | $47.34 B | 13.1% |
2003 | $41.86 B | 15.33% |
2002 | $36.29 B | 10.75% |
2001 | $32.77 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $52.32 B | -42.70% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $68.53 B | -24.95% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $39.95 B | -56.24% | ๐บ๐ธ USA |
![]() Medtronic MDT | $31.55 B | -65.44% | ๐ฎ๐ช Ireland |
![]() Eli Lilly LLY | $32.07 B | -64.88% | ๐บ๐ธ USA |
![]() Sanofi SNY | $49.13 B | -46.19% | ๐ซ๐ท France |
![]() Gilead Sciences GILD | $27.39 B | -70.01% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $19.88 B | -78.23% | ๐บ๐ธ USA |
![]() Merck MRK | $59.31 B | -35.05% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $36.53 B | -59.99% | ๐ฌ๐ง UK |